Judson Hunt, MD
Basic profileJudson Hunt is a Nephrology physician affiliated with Medical City Dallas Hospital. OpenAlex indexes 23 publications with 754 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20222 payments$40
- AstraZeneca Pharmaceuticals LPProgram year20222 payments$31
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20221 payment$21
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
40.8%Statin15.2%Atorvastatin Calcium57%Rosuvastatin Calcium22%Pravastatin Sodium10%Simvastatin10%Part D≥53 patientsAngiotensin receptor blocker (ARB)5.7%Losartan Potassium100%Part D≥29 patients+ 7 more classes in this area
Metabolism & gastrointestinal
17.5%Proton pump inhibitor7.3%Pantoprazole Sodium39%Omeprazole31%Esomeprazole Magnesium21%Aciphex9%Part D<11 patientsH2 blocker3.8%Famotidine100%Part D≥23 patients+ 3 more classes in this area
Anti-infectives
15.9%Short-acting sulfonamides15.9%Sulfamethoxazole-Trimethoprim100%Part D≥80 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation
Journal of the American College of Cardiology
2019 - Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18
American Journal of Transplantation
2018 - Markers of Intermediate-Term Risk After Heart Transplant - Results of the CTOT-18 Study
The Journal of Heart and Lung Transplantation
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Todd Dewey, MD
Medical City Dallas Hospital
Mitchell Magee, MD
Medical City Dallas Hospital
Bruce Bowers, MD
Medical City Dallas Hospital
Irfan Agha, MD
Medical City Dallas Hospital
Laura Svetkey, MD
Duke University
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Rajesh V. Thakker
Queen Mary University of London
Paul Kimmel, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”